AMA supports new FDA labeling on opioids

The Food and Drug Administration (FDA) is requiring new labeling for opioid treatment which focuses on the physician‐patient relationship, and the American Medical Association (AMA) approves. From Bobby Mukkamala M.D., AMA president.